| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/01/2004 | WO2003106495A3 Humanized monoclonal antiboby hpam4 |
| 04/01/2004 | WO2003105754A3 Antisense modulation of vegf-b expression |
| 04/01/2004 | WO2003104402A3 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 04/01/2004 | WO2003102219A9 Improved pseudotyped retroviruses |
| 04/01/2004 | WO2003102131A3 Nucleic acid mediated disruption of hiv fusogenic peptide interactions |
| 04/01/2004 | WO2003100093A3 Method of selecting targets for gene silencing by rna interference |
| 04/01/2004 | WO2003099830A3 Cardiolipin compositions, methods of preparation and use |
| 04/01/2004 | WO2003099225A3 Compositions for delivering nucleic acids to cells |
| 04/01/2004 | WO2003097876A8 Method for improving efficiencies in livestock production |
| 04/01/2004 | WO2003097833A3 Method for the functional artificial evolution of polynucleotide sequences, recombinant polynucleotides obtained and peptides, polypeptides and proteins coded by same |
| 04/01/2004 | WO2003097825A3 Novel phospholipases and uses thereof |
| 04/01/2004 | WO2003095670A3 Process for generating sequence-specific proteases by directed evolution and use thereof |
| 04/01/2004 | WO2003095642A3 Polyepitopes and mini-genes for cancer treatment |
| 04/01/2004 | WO2003093492A3 Compositions and methods for determining susceptibility of hepatitis c virus to anti-viral drugs |
| 04/01/2004 | WO2003092362A3 Seed specific usp promoters for expressing genes in plants |
| 04/01/2004 | WO2003091383A3 Epha2 antigen t epitopes |
| 04/01/2004 | WO2003091381A3 Height-related gene |
| 04/01/2004 | WO2003090667A3 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 04/01/2004 | WO2003089609A3 Short fragment homologous replacement to provide bse resistant cattle |
| 04/01/2004 | WO2003087840A3 Protein involved in cancer |
| 04/01/2004 | WO2003087765A3 System for tracing animal products |
| 04/01/2004 | WO2003085109A3 Method and apparatus for extracting nucleic acids from a complex mixture |
| 04/01/2004 | WO2003083124A3 Peptide epitopes common to antigens of the same multigene family |
| 04/01/2004 | WO2003082911A3 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics |
| 04/01/2004 | WO2003082314A3 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 04/01/2004 | WO2003081978A3 Generation of plants with improved pathogen resistance |
| 04/01/2004 | WO2003080663A3 Tenascin-w compositions and uses thereof |
| 04/01/2004 | WO2003080209A3 Method of concentrating macromolecules or agglomerates of molecules or particles |
| 04/01/2004 | WO2003077868A3 Synthesis of synthons for the manufacture of bioactive compounds |
| 04/01/2004 | WO2003075837A3 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof |
| 04/01/2004 | WO2003075834A3 Activated protein c formulations |
| 04/01/2004 | WO2003074078A3 Cg3842 homologous proteins involved in the regulation of energy homeostasis |
| 04/01/2004 | WO2003072821A3 Method and nucleic acids for the analysis of a colon cell proliferactive disorder |
| 04/01/2004 | WO2003070907A3 Novel fungal lipase |
| 04/01/2004 | WO2003070888A3 Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid |
| 04/01/2004 | WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 04/01/2004 | WO2003070748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/01/2004 | WO2003066877A3 Compositions and methods relating to hepatic specific genes and proteins |
| 04/01/2004 | WO2003064446A3 Plasma protein-binding peptides from bacterial curli |
| 04/01/2004 | WO2003063792A3 Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 04/01/2004 | WO2003063770A3 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 04/01/2004 | WO2003062418B1 Method and apparatus for detecting nucleic acid data |
| 04/01/2004 | WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003059053A3 Rabbit nuclear cloning method and uses thereof |
| 04/01/2004 | WO2003057913A3 Method for the detection and/or identification of the original animal species in animal matter contained in a sample |
| 04/01/2004 | WO2003057841A8 Remote homologues and kinases and methods of detection |
| 04/01/2004 | WO2003054226A3 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 04/01/2004 | WO2003050283A3 A structure for presenting desired peptide sequences |
| 04/01/2004 | WO2003048186A3 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 04/01/2004 | WO2003046214A3 Method for analyzing translation-controlled gene expression |
| 04/01/2004 | WO2003046201A3 Detection and identification of enteric bacteria |
| 04/01/2004 | WO2003045990A3 Protein-protein interactions involving transforming growth factor beta signalling |
| 04/01/2004 | WO2003040286A3 Cdw92 molecule induced immunomodulation |
| 04/01/2004 | WO2003039703A3 Method in the form of a dry rapid test for detecting nucleic acids |
| 04/01/2004 | WO2003038050A3 Antisense modulation of phospholipase a2 group v expression |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003029429A3 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/01/2004 | WO2003029405A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 04/01/2004 | WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/01/2004 | WO2003027328A3 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 04/01/2004 | WO2003025019A8 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 04/01/2004 | WO2003020885A9 Identification of sortase gene |
| 04/01/2004 | WO2003016563A3 Novel molecular target for neurotoxicity |
| 04/01/2004 | WO2003014161A9 Antigen binding domains from fish |
| 04/01/2004 | WO2003012044A9 Hagfish cathelin-associated antimicrobial peptides and genes |
| 04/01/2004 | WO2003004678A3 Novel receptors |
| 04/01/2004 | WO2003000707A8 Antisense modulation of superoxide dismutase 1, soluble expression |
| 04/01/2004 | WO2002097047A3 Compositions and methods for the inference of pigmentation traits |
| 04/01/2004 | WO2002092758A3 Gastrokines and derived peptides including inhibitors |
| 04/01/2004 | WO2002089856A8 Techniques and compositions for treating cardiovascular disease by (in vivo) gene delivery |
| 04/01/2004 | WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2004 | WO2002081676A3 Non-pathogenic bacterial recipient strain of a bacterium containing mycolic acid, method for the production thereof and use of the same |
| 04/01/2004 | WO2002072870A3 Dry solid medium for storage and analysis of genetic material |
| 04/01/2004 | WO2002072774A3 Novel human transporter proteins and polynucleotides encoding the same |
| 04/01/2004 | WO2002072601A3 Apoptosis modulator bcl-b and methods for making and using same |
| 04/01/2004 | WO2002072006A9 METHODS AND REAGENTS FOR IDENTIFYING COMPOUNDS AND MUTATIONS THAT MODULATE DOPAMINE β-HYDROXYLASE ACTIVITY |
| 04/01/2004 | WO2002070676A9 Use of protein histidine phosphatase |
| 04/01/2004 | WO2002064631A3 T1r taste receptors and genes encoding same |
| 04/01/2004 | WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 04/01/2004 | WO2002043654A8 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 04/01/2004 | US20040064859 Transgenic seeds for propagating herbicide, insect and disease resistance plants; tissue engineering |
| 04/01/2004 | US20040064858 Spression of specific classes of soybean seed protein |
| 04/01/2004 | US20040064857 Using agrobacterium to generate transgenic sterility controllable plant model for monitoring heterologous gene expression; tissue engineering |
| 04/01/2004 | US20040064856 Regulatory sequences for controlling heterologous gene expression in plants; tissue engineering |
| 04/01/2004 | US20040064855 Production of lysosomal enzymes in plants by transient expression |
| 04/01/2004 | US20040064854 Expression vector coding prunin (PRU) protein for transformation and generation of plants and seed with enhanced storage capacity |
| 04/01/2004 | US20040064853 Expression vector coding fructosyltransferase for generation of disease and insect resistant plants |
| 04/01/2004 | US20040064852 Using trangenic dicots to produce trisaccharide 1-kestose with low degree of polymerization; forming low caloric sweeteners in plants |
| 04/01/2004 | US20040064851 Transgenic plants which produce isomalt |
| 04/01/2004 | US20040064850 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 04/01/2004 | US20040064849 Use of genes encoding membrane transporter pumps to stimulate the production of secondary metabolites in biological cells |
| 04/01/2004 | US20040064848 Comprises nucleotide sequences coding dehydroquinase/shikimate dehydrogenase for use in high throughput assay which detects herbicides |
| 04/01/2004 | US20040064847 Transgenic plants exhibiting resistance to a spectrum of pathogens |
| 04/01/2004 | US20040064846 Genetic engineering of drought tolerance via a plastid genome |
| 04/01/2004 | US20040064845 Method of cloning animals |
| 04/01/2004 | US20040064844 Cysteine string protein and its role in neurodegenerative diseases |
| 04/01/2004 | US20040064842 Using dispersed regulatory nucleotide sequences to regulate transcription in animal cells, tissues and/or organs; gene expression inhibition |
| 04/01/2004 | US20040064841 Transgenic swine which produce growth factors which facilitate piglet development and decrease mortality; veterinary medicine |
| 04/01/2004 | US20040064262 Insertion with labeled gene; screening for hybrids |